These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25734557)

  • 1. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
    Yamamoto S; Han W; Kim Y; Du L; Jamshidi N; Huang D; Kim JH; Kuo MD
    Radiology; 2015 May; 275(2):384-92. PubMed ID: 25734557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
    Mazurowski MA; Zhang J; Grimm LJ; Yoon SC; Silber JI
    Radiology; 2014 Nov; 273(2):365-72. PubMed ID: 25028781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.
    Sørensen KP; Thomassen M; Tan Q; Bak M; Cold S; Burton M; Larsen MJ; Kruse TA
    Breast Cancer Res Treat; 2013 Dec; 142(3):529-36. PubMed ID: 24258260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
    Ashraf AB; Daye D; Gavenonis S; Mies C; Feldman M; Rosen M; Kontos D
    Radiology; 2014 Aug; 272(2):374-84. PubMed ID: 24702725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
    He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
    Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
    Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
    Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
    Yamamoto S; Maki DD; Korn RL; Kuo MD
    AJR Am J Roentgenol; 2012 Sep; 199(3):654-63. PubMed ID: 22915408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
    Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
    Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging features associated with distant metastasis-free survival of patients with invasive breast cancer: a case-control study.
    Song SE; Shin SU; Moon HG; Ryu HS; Kim K; Moon WK
    Breast Cancer Res Treat; 2017 Apr; 162(3):559-569. PubMed ID: 28185146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer.
    van der Velden BH; Dmitriev I; Loo CE; Pijnappel RM; Gilhuijs KG
    Radiology; 2015 Sep; 276(3):675-85. PubMed ID: 25811614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors.
    Matsubayashi R; Matsuo Y; Edakuni G; Satoh T; Tokunaga O; Kudo S
    Radiology; 2000 Dec; 217(3):841-8. PubMed ID: 11110952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed long noncoding RNAs in bladder cancer.
    Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW
    Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
    Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
    Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
    Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
    Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.